The Michigan Medicaid Health Plan Common Drug Formulary has been updated to include additional medications for weight loss. Changes related to weight loss medications effective February 1, 2022 include:

Drug Class	Drug Name	New Status
Anti-Obesity – Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists	Saxenda Wegovy	Covered on formulary with Prior Authorization and Age Edit - Preferred
Anorexiant Combinations	Qsymia	Covered on formulary with Prior Authorization and Age Edit - Preferred
Anti-Obesity – Fat Absorption Decreasing Agents	Xenical	Covered on formulary with Prior Authorization and Age Edit - Preferred

Each Medicaid Health Plan (MHP) may be less restrictive in their coverage status of these medications. As part of the Common Formulary, minimum requirements are established for drug utilization management policies such as quantity limits, age and gender edits, prior authorization criteria and step therapies. MHPs may be less restrictive, for products whose drug class(es) are not present on the Single Preferred Drug List, but not more restrictive, than the coverage parameters of the Common Formulary.

Click here for the Medicaid Health Plan Common Formulary.